OMALIZUMAB
Tracking # 20-830823
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
OMALIZUMAB IS A RECOMBINANT HUMANIZED IGG1 MONOCLONAL ANTI-IGE ANTIBODY USED IN THE TREATMENT OF ALLERGIC ASTHMA AND CHRONIC URTICARIA. THIS ACTIVITY WILL CONSIDER THE INDICATIONS, CONTRAINDICATIONS, MECHANISMS OF ACTION, ADVERSE EFFECTS, AND MONITORING REQUIREMENTS OF OMALIZUMAB; IT WILL ALSO PROVIDE AN UPDATE ON SOME OF THE KEY STUDIES WHICH HAVE BEEN IMPLEMENTED WITH REGARDS TO ASTHMA PRIMARILY AND INCLUDE URTICARIAL REACTIONS.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Osteopathic Medicine
Osteopathic Physician
1h
General